GKB Ophthalmics Ltd. Corporate Filings & Announcements

Latest corporate announcements and filings from GKB Ophthalmics Ltd. on BSE

Load latest

GKB Ophthalmics Ltd.

18 Apr 2024

65.13

-2.27%

Company Update

GKB OPHTHALMICS LTD. - 533212 - Compliance Certificate Under Regulation 40(9)& 40(10) Of SEBI (Listing Obligations …

BSE India

Pursuant to Regulation 40(10) of SEBI (Listing Obligations and Disclosure Requirements) Regulation, 2015, please find enclosed and Compliance Certificate, issued by Practicing Company Secretary, for the year ended March 31, 2024. Please acknowledge receipt.

pdf

GKB Ophthalmics Ltd.

11 Apr 2024

65.13

-2.27%

Company Update

GKB OPHTHALMICS LTD. - 533212 - Non Applicability Of Circular No. SEBI/HO/DDHS/CIR/P/2018/144, Dated November 26, 2018.

BSE India

Pursuant to Circular no. SEBI/HO/DDHS/CIR/P/2018/144,dated November 26, 2018, issued by the Securities and Exchange Board of India, we hereby confirm that GKB Ophthalmics Limited, is not a "Large Corporate", as defined in the said Circular and hence , the said Circular is not applicable to us. Kindly take the above information on record.

pdf

GKB Ophthalmics Ltd.

08 Apr 2024

65.13

-2.27%

Company Update

GKB OPHTHALMICS LTD. - 533212 - Compliance Certificate Under Regulation 7(3) Of SEBI (Listing Obligations And …

BSE India

Please find herewith the Compliance Certificate under Regulation 7(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, for the financial year ended March 31, 2024.

pdf

GKB Ophthalmics Ltd.

08 Apr 2024

65.13

-2.27%

Company Update

GKB OPHTHALMICS LTD. - 533212 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

BSE India

Please find herewith Certificate under Regulation 74(5) of SEBI(Depositories and Participants) Regulations, 2018, for the quarter ended March 31, 2024. Kindly acknowledge receipt of the same.

pdf

GKB Ophthalmics Ltd.

30 Mar 2024

65.13

-2.27%

Company Update

GKB OPHTHALMICS LTD. - 533212 - Announcement under Regulation 30 (LODR)-Code of Conduct under SEBI (PIT) …

BSE India

Pursuant to provision of Regulation 7(2) read with Regulation 6(2) of SEBI (Prohibition of Insider Trading) Regulation ,2015, intimation be and is hereby given that Mr. K.G. Gupta, Promoter ,Director of the Company , has purchased 1900 equity shares aggregating to Rs. 1,67,699.24/- on 27.03.2024 of the Company, on market. Copy of disclosure required under Regulation 7(2) read with Regulation 6(2) of SEBI (Prohibition of Insider Trading) Regulation,2015, is enclosed herewith. Copy of disclosure received from Mr. K.G.Gupta is also enclosed herewith. Please acknowledge and take the same on record.

pdf

GKB Ophthalmics Ltd.

30 Mar 2024

65.13

-2.27%

Company Update

GKB OPHTHALMICS LTD. - 533212 - Announcement under Regulation 30 (LODR)-Code of Conduct under SEBI (PIT) …

BSE India

pdf

GKB Ophthalmics Ltd.

30 Mar 2024

65.13

-2.27%

Company Update

GKB OPHTHALMICS LTD. - 533212 - Announcement under Regulation 30 (LODR)-Code of Conduct under SEBI (PIT) …

BSE India

Pursuant to provision of Regulation 7(2) read with Regulation 6(2) of SEBI (Prohibition of Insider Trading) Regulation, 2015 (PIT Regulation, 2015), intimation be and is hereby given that Krishna Gopal Gupta & Sons (HUF), has purchased 1397 equity shares aggregating to Rs. 1,23,838.14 /- from 19.02.2024 to 28.03.2024, on market ,which is not exceeding the threshold limit as prescribed under Regulation 7(2) of PIT Regulation, 2015. However, as a good Corporate Governance measure, the disclosure required under Regulation 7(2) read with Regulation 6(2) of PIT Regulation ,2015,is enclosed herewith along with the copy of disclosure received from Krishna Gopal Gupta and Sons-HUF. Please acknowledge and take the same on record.

pdf

GKB Ophthalmics Ltd.

26 Mar 2024

65.13

-2.27%

SAST

GKB OPHTHALMICS LTD. - 533212 - Closure of Trading Window

BSE India

Pursuant to SEBI (Prohibition of Insider Trading) Regulation 2015, as amended from time to time, the "Trading Window" for dealing /trading in the shares of the Company shall remain closed from April 01, 2024, till the completion of 48 hours after the declaration of the financial results of the Company, for the quarter and financial year ended March 31, 2024. Enclosed please find the disclosure. Kindly take the information on record.

pdf

GKB Ophthalmics Ltd.

20 Mar 2024

65.13

-2.27%

Company Update

GKB OPHTHALMICS LTD. - 533212 - Revised - Regulation 30 Of SEBI ( Listing Obligations And …

BSE India

Pursuant to Regulation 30 , SEBI ( Listing Obligations and Disclosure Requirements) Regulations 2015, enclosed please find the revised disclosure pertaining to the resignation of Mr. Subhash Redkar as Executive / Whole Time Director due to his immediate appointment without any Notice period as Principal in Industrial Training Institute, Senior Gazetted Officer, in Government of Goa and thereby resulting in delay in intimation. Enclosed is the resignation of Mr. Subhash Redkar. The Board of Directors in its meeting held on March 19, 2024, accepted the said resignation and reconstituted the Committees of the Board as per the enclosed disclosure. We regret the inconvenience caused and request to take the above information record.

pdf

GKB Ophthalmics Ltd.

19 Mar 2024

65.13

-2.27%

Company Update

GKB OPHTHALMICS LTD. - 533212 - Announcement under Regulation 30 (LODR)-Resignation of Director

BSE India

Pursuant to Regulation 30 of the Securities and Exchange Board of India ( Listing Obligations and Disclosure Requirements) Regulations, 2015 enclosed please find the disclosure pertaining to the resignation of Mr. Subhash Redkar as Executive / Whole Time Director of the Company w.e.f. March 16, 2024. The Board of Director in its meeting held today, i.e. March 19, 2024, accepted the resignation of Mr. Subhash Redkar as Executive/ Whole Time Director of the Company and thereafter reconstituted the Committees of the Board. The said details and a copy of the resignation letter is enclosed as Annexure A. Kindly take the information on record.

pdf

Is GKB Ophthalmics Ltd. worth buying?

12 Votes:

Buy 66.67%

Sell 33.33%